A detailed history of Tobam transactions in Abbott Laboratories stock. As of the latest transaction made, Tobam holds 8,436 shares of ABT stock, worth $863,255. This represents 0.09% of its overall portfolio holdings.

Number of Shares
8,436
Previous 9,088 7.17%
Holding current value
$863,255
Previous $1 Million 4.1%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$109.52 - $120.96 $71,407 - $78,865
-652 Reduced 7.17%
8,436 $959,000
Q4 2023

Jan 26, 2024

BUY
$90.19 - $110.4 $18,939 - $23,184
210 Added 2.37%
9,088 $1 Million
Q3 2023

Oct 31, 2023

SELL
$95.53 - $114.62 $76,137 - $91,352
-797 Reduced 8.24%
8,878 $860,000
Q2 2023

Jul 31, 2023

BUY
$100.78 - $112.29 $32,652 - $36,381
324 Added 3.46%
9,675 $1.06 Million
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $32,060 - $37,737
-331 Reduced 3.42%
9,351 $947,000
Q4 2022

Feb 02, 2023

BUY
$95.06 - $111.52 $60,172 - $70,592
633 Added 7.0%
9,682 $1.06 Million
Q3 2022

Nov 02, 2022

SELL
$96.76 - $112.03 $32,995 - $38,202
-341 Reduced 3.63%
9,049 $876,000
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $66,549 - $80,437
652 Added 7.46%
9,390 $1.02 Million
Q1 2022

Apr 25, 2022

BUY
$114.02 - $139.04 $375,923 - $458,414
3,297 Added 60.6%
8,738 $1.03 Million
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $39,395 - $48,237
-341 Reduced 5.9%
5,441 $766,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $100,677 - $111,378
863 Added 17.54%
5,782 $683,000
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $133,718 - $157,405
1,264 Added 34.58%
4,919 $570,000
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $127,560 - $150,285
1,172 Added 47.2%
3,655 $438,000
Q4 2020

Feb 03, 2021

BUY
$105.0 - $114.42 $68,040 - $74,144
648 Added 35.31%
2,483 $272,000
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $168,159 - $204,217
1,835 New
1,835 $200,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.